boehringer-ingelheim-venture.com
HomeInvestment strategy read more Our Team
http://www.boehringer-ingelheim-venture.com/
Investment strategy read more Our Team
http://www.boehringer-ingelheim-venture.com/
TODAY'S RATING
#680,000
Date Range
HIGHEST TRAFFIC ON
Thursday
LOAD TIME
2.3 seconds
16x16
Boehringer Ingelheim International GmbH
3460-02-06 Corporate Department Trademarks
Binger●●●●●●se 173
Ing●●●eim , D - 55216
DE
View this contact
Boehringer Ingelheim GmbH
3344-EG-04 I*Net Solution Center
Abteilung I●●●●●●●●●●●erarbeitung
Ing●●●eim , Rheinland-Pfalz, D-55216
DE
View this contact
Corporation Service Company
Domain Registrar
PO ●●●597
Yar●●●uth , NS, B5A 4B4
CA
View this contact
BUY YOUR DOMAIN
14
YEARS
2
MONTHS
19
DAYS
CSC CORPORATE DOMAINS, INC.
WHOIS : whois.corporatedomains.com
REFERRED : http://www.cscglobal.com
PAGES IN
THIS WEBSITE
10
SSL
EXTERNAL LINKS
28
SITE IP
64.106.209.186
LOAD TIME
2.289 sec
SCORE
6.2
Home | boehringer-ingelheim-venture.com Reviews
https://boehringer-ingelheim-venture.com
Investment strategy read more Our Team
boehringer-ingelheim-venture.com
Application for Funding
http://www.boehringer-ingelheim-venture.com/funding.html
Boehringer Ingelheim Venture Fund 07 July 2016. Jump to main navigation. Submitting a business plan for initial review by one of our experienced investment team is a simple and straightforward 3-step process. We prefer to receive submissions online and invite you to submit your non-confidential information using the template provided for the quickest response to your application. Complete the online application form, ensuring all fields are completed. Submit your Business Plan or Concept now.
Accessibility Statement
http://www.boehringer-ingelheim-venture.com/muc/footer/accessibility_statement.html
Boehringer Ingelheim Venture Fund 07 July 2016. Jump to main navigation. Accessibility Statement for Boehringer Ingelheim websites. Hot Keys provide short cuts to certain pages within the web site. To use the access keys hold down the ‘Alt’ key and enter the ‘Hot key’ number. The following shortcut Hot keys are active on the Boehringer Ingelheim website:. Multimedia elements: Images, video and audio files. Presentation of Content and Layout. Tables and bullet list for helping readers. In the meantime, sh...
Imprint
http://www.boehringer-ingelheim-venture.com/muc/footer/imprint.html
Boehringer Ingelheim Venture Fund 07 July 2016. Jump to main navigation. 55216 Ingelheim / Rhein, Germany. District Court: Mainz, HRB 21005. Identification number for turnover tax: DE 81 11 37 994. Board of Managing Directors:. Chairman of the Shareholders' Committee. For queries please click here.
Our Team
http://www.boehringer-ingelheim-venture.com/team.html
Boehringer Ingelheim Venture Fund 07 July 2016. Jump to main navigation. We have a dedicated team of highly skilled and experienced investment and pharmaceutical professionals ready to support and work with you. Vice President, Head of the Boehringer Ingelheim Venture Fund. Located in Ingelheim, Germany. Director, Investment Manager of the Boehringer Ingelheim Venture Fund. Located in Ingelheim, Germany. Director, Investment Manager of the Boehringer Ingelheim Venture Fund. Located in Cambridge, US.
Partnering with us
http://www.boehringer-ingelheim-venture.com/facts_figures.html
Boehringer Ingelheim Venture Fund 07 July 2016. Jump to main navigation. Our Philosophy and Investment Strategy. Should convince you of the uniqueness of the Boehringer Ingelheim Venture Fund (BIVF) as a visionary, trustful and value-adding partner. Strategic: Create options for the corporation to expand into new therapeutic approaches and businesses. Add value: Help innovators develop their concept from idea to Proof of Concept. Secure financial return to support continuity - Evergreen Fund Model. No fl...
TOTAL PAGES IN THIS WEBSITE
10
partnering.boehringer-ingelheim.com
Partnering News
http://partnering.boehringer-ingelheim.com/partnering_news_andevents/press_releases.html
What You Can Expect. Boehringer Ingelheim Partnering Key Contacts. Working Together Newsletter - NEW. Boehringer Ingelheim Venture Fund. Boehringer Ingelheim and Lilly Announce Clinical Trial Collaboration in Metastatic Breast Cancer. Boehringer Ingelheim and Harvard scientists establish a research alliance to find novel treatments for severe fibrotic diseases. Boehringer Ingelheim and Inventiva collaborate to develop potential new treatments for idiopathic pulmonary fibrosis.
Investors - PCOVERY
http://pcovery.com/index.php/about-pcovery/investors
Pcovery was founded in 2009 aided by a pre-Seed grant from Novo Seeds. The first Seed round was made in 2010 by Østjysk Innovation and Novo Seeds. In 2013 a second Seed round was made by the existing investors. Also in 2013 Pcovery received a Seeding Drug Discovery Award of up to 3.7 m from the Wellcome Trust. Boehringer Ingelheim Venture Fund. The Boehringer Ingelheim Venture Fund was formed in March 2010 to invest in biotechnology and start-up companies to help drive innovation in medical science. ...
Eyevensys
http://www.eyevensys.com/pages/17-investors.html
The Eyevensys Breakthrough Technology. Eyevensys was incepted late 2008, but it was only in January 2012 that it completed an initial seed financing of EUR 1.6 million. As of June 2015 the Company has raised 8,1 M , and has further secured additional funds from investors and public sources to fully support through its Phase I clinical program. Boehringer Ingelheim Venture Fund. Founded in 2000, InsermTransfert SA is the private subsidiary of the French National Institute of Health and Medical Research (I...
partnering.boehringer-ingelheim.com
News and Events
http://partnering.boehringer-ingelheim.com/partnering_news_andevents.html
What You Can Expect. Boehringer Ingelheim Partnering Key Contacts. Working Together Newsletter - NEW. Boehringer Ingelheim Venture Fund. Partnering News, Publications and Events. Please click on the links below for quick access to recent news highlights on Boehringer Ingelheim partnerships, our scientific publications and events where you can meet the Boehringer Ingelheim partnering team. Find out more about our recent partnering news. Find out where you can meet the Boehringer Ingelheim partnering team.
partnering.boehringer-ingelheim.com
Meet Our Team
http://partnering.boehringer-ingelheim.com/meet_the_team.html
What You Can Expect. Boehringer Ingelheim Partnering Key Contacts. Working Together Newsletter - NEW. Boehringer Ingelheim Venture Fund. Our team is ready to work together with you. Our partnering team brings a wealth of experience and knowledge to every relationship we have with our partners, seeking to create an environment that fosters scientific collaboration and trust. We hope you will join us very soon in. And help make a difference to patients’ lives. Global Business Development and Licensing.
partnering.boehringer-ingelheim.com
Our Partnering Focus
http://partnering.boehringer-ingelheim.com/our_focus.html
What You Can Expect. Boehringer Ingelheim Partnering Key Contacts. Working Together Newsletter - NEW. Boehringer Ingelheim Venture Fund. Our partnering activities encompass opportunities across the entire drug discovery and development value chain:. 1 Focusing on the discovery and development of new and/or better medications for patients in our areas of therapeutic focus. 3 Harnessing emerging science and technology within and beyond our therapeutic areas Research Beyond Borders.
TOTAL LINKS TO THIS WEBSITE
28
Boehringer Ingelheim - Animal Health
Animal Health 10 August 2015. Jump to main navigation. Jump to meta navigation. Bestel hier het Zakboek Varkens. Darmgezondheid: Met sprongen vooruit! Subklinische PIA: Onzichtbare kostenpost. Handige mail tool voor dierenartsen. Een varkenshouder zal er alles aan doen om te voorkomen dat zijn dieren ziek worden". Producten en medicijnen voor. Klik hier voor meer informatie. Klik hier voor meer informatie. 20 t/m 22 oktober 2015. Klik hier voor meer informatie. Over BI Animal Health.
boehringer-ingelheim-bigband.de
Boehringer Ingelheim BigBand - Home
Die wohl schönste Einstimmung auf Weihnachten 2014. Starten Sie mit der Boehringer Ingelheim BigBand musikalisch in die Vorweihnachtszeit. Denn diese hat sich für Ihr Jahreskonzert ein weiteres, wunderbares Programm ausgedacht. Freuen Sie sich auf Klassiker, modernere Stücke und auch weihnachtliche BigBand Arrangements. Und so können Sie am 29.November 2014 einen. Zur Einstimmung auf den 1.Advent verbringen. Albrecht-Dürer-Str. 10. Einlass: 19.00 Uhr. Beginn: 20.00 Uhr. Keine Scheu vor modernen Hits.
boehringer-ingelheim-chor-biberach.de
Boehringer Ingelheim-Chor Biberach
Jump to main navigation. Jump to meta navigation. Herzlich willkommen beim Boehringer Ingelheim-Chor Biberach. Derzeit sind ca. 45 Sängerinnen und Sänger aktiv im Chor. Beim Chor ist kein Beitrag zu entrichten. Die Proben finden dienstags von 18.30 bis 20 Uhr. Im Jazzkeller der Jugendmusikschule statt. Über eine kurze Kontaktaufnahme mit Monika Mittnacht. Würden wir uns freuen.
boehringer-ingelheim-ipfposters.com
Conference Posters
Patientenberichtete Endpunkte in der TOMORROW-Studie']);" href="http:/ boehringer-ingelheim-ipfposters.com/wp-content/uploads/2014/03/BiOc PosterNintedanib1401 2003.pdf" Behandlung der Idiopathischen Lungenfibrose (IPF) mit dem Tyrosinkinaseinhibitor Nintedanib: Patientenberichtete Endpunkte in der TOMORROW-Studie.
boehringer-ingelheim-stiftung.de
The Foundation: BI-Stiftung
Skip to main content. Https:/ www.boehringer-ingelheim-stiftung.de/. Initiatives for the Region. Mainz PhD Student Prizes. Lasting support for excellent science. The Boehringer Ingelheim Foundation is an independent, non-profit foundation. We promote excellent basic research in medicine, biology, chemistry, and pharmacy for important, sometimes ground-breaking, new insights that lastingly ensure our health and quality of life. Our objectives and guiding principles. The Foundation's bodies and offices.
boehringer-ingelheim-venture.com
Home
Boehringer Ingelheim Venture Fund. Boehringer Ingelheim Venture Fund. 55216 Ingelheim am Rhein. Phone 49 6132 77 8740.
Homepage | boehringer-ingelheim.at
Skip to main content. Audit Beruf und Familie. Erkrankungen des Zentralen Nervensystems. Institut für Molekulare Pathologie. Werte schaffen durch Innovation. Boehringer Ingelheim ist ein weltweit tätiges, forschendes Pharmaunternehmen, bei dem Menschen aus vielen verschiedenen Kulturen zusammenarbeiten. Anschauen the video on Unsere Vision. Worauf wir uns konzentrieren. Mehr on Worauf wir uns konzentrieren. Integriertes Kompetenzzentrum für Arzneimittelforschung in der Onkologie. 500 neue Jobs LSCC.
Boehringer Ingelheim - La valeur par l’innovation
Skip to main content. Nous améliorons la santé avec passion. Boehringer Ingelheim est une société pharmaceutique mondiale axée sur la recherche englobant de nombreuses cultures et diverses communautés. Les objectifs et convictions du groupe d’entreprises Boehringer Ingelheim peuvent être résumés en quelques mots : La valeur par l’innovation, le concept central de notre vision d’entreprise. Visionner the video on Notre vision. Notre approche de la découverte. Lire plus on Notre approche de la découverte.
Boehringer Ingelheim - Value Through Innovation
Skip to main content. Research and development sites. Burlington - Head Office. We passionately improve health. Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies. The Boehringer Ingelheim group of companies' objectives and beliefs can be summed up in a single phrase: Value through Innovation, the central concept of our corporate vision. Animal Health: One business, one vision, one global leader in disease prevention and treatment. Boehr...
Homepage | boehringer-ingelheim.ch
Skip to main content. Werte - Vertrauen durch Transparenz. Herzlich Willkommen bei Boehringer Ingelheim Schweiz. Wir schaffen Werte durch Innovation! Werte - Vertrauen durch Transparenz.
Boehringer Ingelheim 勃林格殷格翰 - 创新创造价值
Skip to main content. PRESS RELEASE 18 十二月 2017 - 14:02. PRESS RELEASE 02 八月 2017 - 11:37.
